Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
- Conditions
- Diagnoses DiseaseCovid19
- Interventions
- Behavioral: Doctorgram Patient Kit
- Registration Number
- NCT04480411
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of this study is to assess the use of technology including remote vital sign monitoring in improving quality of patient care, decreasing hospital admissions and re-admissions, decreasing hospital length of stay and decreasing use of personal protective equipment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed with COVID 19
- Clinically stable (on 4L O2 or less, non ICU)
- Demonstrates ability to be trained in use of digital stethoscope technology
- Pregnancy
- Delirium
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description COVID-19 Patients Doctorgram Patient Kit Patients that are admitted to the hospital with COVID 19.
- Primary Outcome Measures
Name Time Method Patient provider experience survey score Once after completion of device use (up to 15 minutes to complete the survey) Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).
Provider experience survey score Once after completion of device use (up to 15 minutes to complete the survey) Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).
Use of personal protective improvement 6 months Level of personal protective improvement in an in-patient setting.
Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University
πΊπΈStanford, California, United States